Congenica is a world leading developer of genome-based discovery and diagnostic technologies. Congenica is a spin-out from The Wellcome Trust Sanger Institute. It was founded by six world leading geneticists and bioinformaticians in genomic sequencing, including Dr Richard Durbin who led the international 1000 Genomes Project and the UK 100,000 Genomes Project, and Dr Matthew Hurles, Senior Group Leader at the Wellcome Trust Sanger Institute and a leader in the Deciphering Developmental Disorders (DDD) project. Congenica has developed SapientiaTM technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. It is based on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and regional genetic testing laboratories. This underlying technology has been validated by leading independent institutes and clinicians, including Genomics England Ltd.